Skip to main content

Key new drugs help close out 2024

New biologics for breast cancer, hemophilia, and a rare form of heart disease are poised to add competition and choice in these classes.

Welcome to the Fall 2024 Notable New Drugs Report

New treatments target relatively small, hard-to-treat patient populations with big drug spend.

This edition of the report showcases:

  • A first-in-class treatment for both A and B hemophilia which can reduce the frequency of bleeding episodes.
  • A new addition to standard breast cancer therapy with improved outcomes for people with HR-positive breast cancer.
  • A new drug to treat a rare congenital heart disease can reduce the risk of death by 57%.

Don't want to read the full report? Download the summary.

Gain access to this resource

Please complete the form below to get the insights you're looking for.

Related healthcare insights

View all

E-book

3 steps to slash medication costs

This is your employer guide to reducing your healthcare spending.

Video

Optum Rx customer obsession

Watch how one Optum Rx employee made the system work better for everyone.

E-book

Are your pharmacy benefits working hard enough?

Pharmacy benefits should be transparent, affordable and easy to use. Get clear on your pharmacy benefit manager’s value with these 3 questions.